Skip to main content

Animations

MJFF Publications

6421 - 6430 of 8824 Results
Title
Year
  • Year
  • 2025
  • 2025
  • 2025
  • 2025
  • 2025
  • 2024
  • 2025
  • 2015
  • 2025
  • 2025
  • Summary Details
    OPEN
    Title: Association between serum sodium and sporadic Parkinson’s disease
    Journal Name: Frontiers in Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnins.2025.1555831
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Dopamine Transporter Imaging as Objective Monitoring Biomarker in Parkinson's Disease
    Journal Name: Annals of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/ana.27223
    Citation Count: 15
  • Summary Details
    OPEN
    Title: AskBeacon—performing genomic data exchange and analytics with natural language
    Journal Name: Bioinformatics
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1093/bioinformatics/btaf079
    Citation Count: 0
  • Summary Details
    RESTRICTED
    Title: Multi-cohort cerebrospinal fluid proteomics identifies robust molecular signatures across the Alzheimer disease continuum
    Journal Name: Neuron
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.neuron.2025.02.014
    Citation Count: 40
  • Summary Details
    OPEN
    Title: Safety and Feasibility of Serial Lumbar Punctures: Long-term Results from the Parkinson’s Progression Markers Initiative
    Journal Name: Clinical Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.prdoa.2025.100385
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Proteogenomic analysis of human cerebrospinal fluid identifies neurologically relevant regulation and implicates causal proteins for Alzheimer’s disease
    Journal Name: Nature Genetics
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/s41588-024-01972-8
    Citation Count: 59
  • Summary Details
    OPEN
    Title: A blood-based DNA damage signature in patients with Parkinson’s disease is associated with disease progression
    Journal Name: Nature Aging
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s43587-025-00926-x
    Citation Count: 5
  • Summary Details
    OPEN
    Title: Predicting the risk of mild cognitive impairment in the Mayo Clinic Study of Aging
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0000000000001437
    Citation Count: 149
  • Summary Details
    OPEN
    Title: FLIMPA: A Versatile Software for Fluorescence Lifetime Imaging Microscopy Phasor Analysis
    Journal Name: Analytical Chemistry
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1021/acs.analchem.5c00495
    Citation Count: 6
  • Summary Details
    OPEN
    Title: Molecular Insight into Amyloid Fibril-Templated Aggregation of Biomarkers
    Journal Name: ACS Chemical Neuroscience
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1021/acschemneuro.5c00103
    Citation Count: 1
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.